ArticleFrontiers in medicine2025
Diagnosis model for assessing chronic thromboembolic pulmonary hypertension in high-altitude pulmonary embolism patients: a machine learning approach.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Predictive Value of the Combined FVC/DLCO Ratio and 1-Minute Heart Rate Recovery After Exercise in Stable Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.International journal of general medicine · 2026Article
- Artificial intelligence in neurocardiology: decoding brain-heart network interactions for clinical and translational insights.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with pulmonary embolism (PE) at high altitude face an increased risk of developing chronic thromboembolic pulmonary hypertension (CTEPH). This study aims to establish a diagnosis model of CTEPH patients at high altitude to optimize early screening. Methods: A retrospective cohort of CTEPH and PE patients was rigorously selected through inclusion/exclusion criteria. Clinical data encompassing biochemical profiles, echocardiography, and CT angiography (CTA) were collected, yielding 103 candidate variables. Feature parameters were screened using the Boruta algorithm, followed by predictive model development with seven machine learning architectures. The optimal model was identified based on area under the curve (AUC). The optimal Random Forest model was subsequently interpreted through Shapley Additive Explanations (SHAP) to quantify feature contributions. Results: Among 57 PE patients, 44% met echocardiographic criteria for pulmonary hypertension following PE. Diameter of right atrium, diameter of right ventricle, Vessel-Grade (of embolization) and Sup-inferior (superior or inferior of embolization) were key identified predictors. Random Forests model had the highest AUC of 0.842. Enlarged right heart, embolization of small vessels and superior pulmonary artery embolism increased the risk of CTEPH, while normal right heart structure and isolated inferior pulmonary embolism reduced it. Conclusion: The Random Forests model demonstrated potential for detecting CTEPH in PE patients, enabling early and rapid pulmonary hypertension assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.